Based on the demonstrated low incidence of PHD2, lack of PHD3 protein and high incidence of HIF-α in ccRCC, we expect that HIF-α mediated drug resistance is particularly important in this type of cancer. Here, EGLN1 is linked to nonpapillary renal cell carcinoma.